IMPORTANT DISCLAIMER: Blank Capital Research ("BCR") is a technology platform, not a registered investment advisor or broker-dealer. The algorithmically generated signals, scores, and rankings provided on this site ("God Mode" Signals) are for informational and research purposes only and do not constitute financial advice, investment recommendations, or an offer to sell or solicit an offer to buy any securities.
HYPOTHETICAL PERFORMANCE RESULTS: The "timing scores" and "regime signals" displayed are based on quantitative models. Hypothetical or simulated performance results have certain inherent limitations. Unlike an actual performance record, simulated results do not represent actual trading. Also, since the trades have not actually been executed, the results may have under-or-over compensated for the impact, if any, of certain market factors, such as lack of liquidity.
RISK OF LOSS: Trading in financial markets involves a high degree of risk and may result in the loss of your entire investment. Data provided by third-party sources (Intrinio, Snowflake) is believed to be reliable but is not guaranteed for accuracy or completeness. Past performance is not indicative of future results.
© 2026 Blank Capital Research. All rights reserved. System Version: Aegis V8 (God Mode).
Verdict
Quantitative factor alignment verified for current market regime.
Quant Score
Rank
#1019
Positioning
Market Dominance
Services
Business Services
$295M
Michael D. Hays
National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, health risk assessments, employee engagement, reputation management, and brand loyalty.
Headcount
490
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Dates updated upon official exchange announcement.
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
X-AXIS: EV/EBITDA (LOWER = CHEAPER) | Y-AXIS: ROE (HIGHER = ELITE) | RED CIRCLE = NRC ANALYSIS TARGET
| Stock | Rating | Score▼ | Quality | Value | Momentum | P/E | EV/EBITDA | ROE | ROA | Gross Mgn | Op Mgn | Net Mgn | Rev Growth | Div Yield | D/E | Mkt Cap | AUDIT |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
$YALA Yalla Group Ltd | 75 | 89 | 99 | 80 | - | - | 21.3% | 18.6% | 64.5% | 35.7% | 39.5% | 6.5% | 0.0% | 0.0x | $644M | VS | |
$GRVY GRAVITY Co., Ltd. | 75 | 82 | 96 | 71 | - | - | 15.4% | 12.6% | 38.7% | 17.1% | 17.0% | -39.7% | 0.0% | 0.0x | $439M | VS | |
$ISSC INNOVATIVE SOLUTIONS & SUPPORT INC | 73 | 81 | 88 | 94 | 25.0x | 14.1x | 28.1% | 16.8% | 48.1% | 23.8% | 18.5% | 78.6% | 0.0% | 37.0x | $220M | VS | |
$AER AerCap Holdings N.V. | 72 | 60 | 87 | 84 | - | - | 12.4% | 2.9% | 100.0% | 28.2% | 26.2% | 5.5% | 0.8% | 264.0x | $19.4B | VS | |
$HCSG HEALTHCARE SERVICES GROUP INC | 72 | 74 | 88 | 88 | 7.1x | 6.1x | 28.9% | 20.8% | 20.8% | 9.9% | 9.3% | 8.5% | 0.0% | 1.0x | $1.2B | VS | |
$LQDT LIQUIDITY SERVICES INC | 72 | 90 | 88 | 68 | 24.9x | 14.3x | 14.6% | 7.8% | 43.8% | 7.4% | 5.9% | 31.2% | 0.0% | 0.0x | $857M | VS | |
$TRTNpA Triton International Ltd | 71 | 70 | 89 | 70 | - | 1.7x | 18.0% | 4.6% | 97.3% | 52.2% | 32.7% | -3.4% | 0.0% | 271.0x | $8.0B | VS | |
$EDU New Oriental Education & Technology Group Inc. | 71 | 83 | 52 | 77 | - | - | 9.4% | 4.9% | 55.5% | 8.7% | 7.7% | 13.6% | 1.3% | 7.0x | $78.0B | VS | |
$NTES NetEase, Inc. | 71 | 88 | 93 | 68 | - | - | 22.1% | 15.6% | 62.5% | 28.1% | 28.7% | -1.0% | 2.8% | 9.0x | $56.6B | VS | |
$UTI UNIVERSAL TECHNICAL INSTITUTE INC | 70 | 86 | 86 | 72 | 43.2x | 16.0x | 21.4% | 8.0% | 100.0% | 10.0% | 7.5% | 14.1% | 0.0% | 27.0x | $1.8B | VS | |
$NRC NATIONAL RESEARCH CORP | 57 | 74 | 69 | 65 | 20.0x | 9.4x | 108.2% | 11.4% | 61.1% | 18.7% | 11.2% | -1.2% | 3.8% | 848.0x | $295M | ||
| SECTOR BENCH | - | - | - | - | - | 23.7x | 11.7x | 5.3% | 1.9% | 59.6% | 3.5% | 2.3% | 7.8% | 0.0% | 0.3x | - | REF |
NATIONAL RESEARCH CORP (NRC) receives a "Hold" rating with a composite score of 57.1/100. It ranks #1019 out of 7,333 stocks in our coverage universe and carries a 3-star rating. Ratings are driven by a 6-factor quantitative model measuring quality, value, momentum, investment, stability, and short interest.
Sign in to join the discussion.
YOY expansion rate
Core pricing power
Operating efficiency
Bottom-line conversion
Equity capital efficiency
Asset base utilization
Financial leverage load
Direct cash return
Michael D. Hays
Chief Executive Officer
Labor Force
490
74
38
52
Audit Verdict: Average governance indicators based on financial metrics.
No recent insider transactions available for NRC
HQ Base
Lincoln, Nebraska
Outperforming peers — winners tend to keep winning over 3-12 months
Trading at a discount to fundamentals — favorable entry valuation
High profitability & efficiency — strong quality floor supports entry
Average volatility — neutral timing signal
Moderate investment profile
Mid-range overall rating
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Relative valuation derived from Services sector benchmarks. Model weights: EV/EBITDA (40%), P/B (35%), P/S (25%). Re-calculated daily.
Projection based on user-defined inputs. Re-calculated daily against current market data.
Reverse DCF Framework — Mauboussin Methodology
Institutional-grade Reverse DCF analysis. This model identifies the growth hurdles embedded in current market prices. When implied growth is significantly lower than historical or projected rates, a margin of safety may exist. Re-audited daily.
No analyst ratings for NRC.
View All RatingsMaterial decline in asset turnover efficiency detected
| Factor | Global | Sector | Tilt |
|---|---|---|---|
| PROFITABILITY | 74 | 89 | -15DRAG |
| MOMENTUM | 65 | 74 | -9DRAG |
| VALUATION | 69 | 78 | -9DRAG |
| INVESTMENT | 38 | 64 | -26DRAG |
| STABILITY | 52 | 54 | -2NEUTRAL |
| SHORT INT | 49 | 48 | +1NEUTRAL |
Global = full universe. Sector = relative to industry peers. Positive tilt indicates idiosyncratic strength.
ROIC 6.5% vs WACC 8.0% (spread -1.5%)
GM 61% vs sector 60%, OM 19% vs sector 4%
Capital turnover 0.44x
Rev growth -1%, 10yr history
Interest coverage 5.3x, Net debt/EBITDA 7.8x
Composite assessment of profitability, capital efficiency, and financial strength. Top-tier entities demonstrate sustainable cash flow generation and elite competitive moats.
Profit generated per dollar of shareholder equity
Efficiency of asset utilization
Pricing power and cost efficiency
Core business profitability
Bottom-line profitability
The Quality factor evaluates the persistence and magnitude of realized cash flows. Companies with scores >70 exhibit superior pricing power and structural financial resilience through diverse economic regimes.
Our uncertainty rating tracks the predictability of future cash flows and potential for permanent capital loss. Moderate visibility with standard industry cyclicality.
Our model assigns NATIONAL RESEARCH CORP a Hold rating, with a composite score of 57.1/100 and 3 out of 5 stars. Ranked #1019 of 7,333 stocks, NRC presents a mixed quantitative picture — neither compelling enough to initiate new positions nor weak enough to warrant selling. Investors already holding may consider maintaining their position while monitoring for changes in the factor profile.
NRC earns a quality score of 74/100, indicating above-average business quality. The company reports a return on equity of 108.2% (sector avg: 5.3%), gross margins of 61.1% (sector avg: 59.6%), net margins of 11.2% (sector avg: 2.3%). Companies in this tier generally demonstrate consistent profitability and efficient capital deployment, though they may face some competitive pressure.
NRC's value score of 69/100 indicates the stock is fairly valued based on its current fundamentals. Key valuation metrics include a P/E ratio of 19.98x, an EV/EBITDA of 9.40x, a P/B ratio of 21.62x. At this level, neither a clear bargain nor overpriced, the stock's attractiveness depends more on forward growth expectations and qualitative factors.
NATIONAL RESEARCH CORP's investment score of 38/100 suggests limited reinvestment activity. Key growth metrics include revenue growth of -1.2% vs. a sector average of 7.8% and a return on assets of 11.4% (sector: 1.9%). While this can be positive for mature, cash-generative businesses returning capital to shareholders, it may also signal a lack of growth opportunities or management conservatism.
NRC demonstrates moderate momentum with a score of 65/100, suggesting a neutral price trend without strong directional conviction. Revenue growth stands at -1.2% year-over-year, while a beta of 0.82 reflects its sensitivity to broader market moves. Moderate momentum may indicate the stock is consolidating or transitioning between trends, warranting close monitoring of upcoming catalysts.
With a stability score of 52/100, NRC exhibits average financial resilience. Key stability metrics include a beta of 0.82 and a debt-to-equity ratio of 848.00x (sector avg: 0.3x). While the balance sheet is not a major concern, the stock is subject to typical market volatility and may experience sharper drawdowns during risk-off episodes.
The short interest score of 49/100 for NRC suggests somewhat elevated bearish positioning by institutional traders. Specific risk factors include elevated leverage (D/E: 848.00x), micro-cap liquidity risk. With a $295M market cap (micro-cap), NATIONAL RESEARCH CORP may experience above-average volatility. Investors should consider whether the short thesis has merit or if it creates a potential short-squeeze opportunity.
NRC pays a solid dividend yield of 3.8%, contributing an income component to total returns. This moderate yield suggests a balance between returning capital to shareholders and retaining earnings for reinvestment — a common profile among quality compounders.
NATIONAL RESEARCH CORP is a micro-cap company in the Services sector, ranked #0 of 50 in its sector (100th percentile) and #1019 of 7,333 overall (86th percentile). Key comparisons include ROE of 108.2% exceeding the 5.3% sector median and operating margins of 18.7% above the 3.5% sector average. This top-quartile standing reflects exceptional competitive strength relative to Services peers.
While NRC currently exhibits a HOLD profile, superior opportunities exist within the SERVICES sector. Our model identifies several "Strong Buy" candidates with higher quality scores and more attractive valuations among direct industry competitors.
View Top Services Alpha →Quant Factor Profile
Upgrade catalyst
Investment (38) is the limiting factor — improvement here would lift the composite score most.
EV/EBITDA 20% BELOW SECTOR MEDIAN (FAVORABLE)
ROE 1938% ABOVE SECTOR MEDIAN (FAVORABLE)
Gross Margin IN LINE WITH SECTOR BENCHMARKS
AUDIT DATA AS OF SEP 30, 2025 (Q2 FY2025)
We rate NATIONAL RESEARCH CORP (NRC) as a Hold with a composite score of 57.1/100 at a current price of $12.50. The stock presents a mixed quantitative picture — neither compelling enough to warrant new accumulation nor weak enough to justify selling for existing holders. Our factors are split, and the overall profile suggests patience is warranted.
The rating is primarily driven by strength in quality (74th percentile) and value (69th percentile), which together account for the majority of the composite score. Offsetting weakness in investment (38th percentile) and stability (52th percentile) tempers our overall conviction. We assign a No Moat rating (37/100), High uncertainty, and Standard capital allocation.
Key items to watch: whether strong momentum is fundamentally supported by revenue trends; balance sheet deleveraging progress. Any material change in these dynamics could warrant a reassessment of our rating. The moat trend is stable, which suggests the competitive landscape is stable for now.
NATIONAL RESEARCH CORP holds a top-quartile position (#0 of 50) within the Services sector, based on our composite quantitative scoring across quality, value, momentum, and stability factors. The composite score of 57.1/100 places it at rank #1019 in our full 7,333-stock universe. At $295M in market capitalization, NATIONAL RESEARCH CORP is a small-cap player in the Services space, which limits certain scale advantages but may allow for more agile strategic execution.
Despite positive momentum (65th percentile), revenue contraction of -1% creates a divergence between price action and fundamental trajectory. This divergence suggests either that the market is looking through near-term weakness or that technical factors are temporarily inflating the stock. Investors should assess whether the revenue decline reflects cyclical weakness or structural challenges.
The margin cascade tells an important story: gross margins of 61% (+1.5pp vs sector) narrow to operating margins of 19% (+15.2pp vs sector) and net margins of 11.2%, yielding a gross-to-net conversion rate of 18%. This conversion rate is typical for the sector, suggesting a standard cost structure without notable efficiency advantages or disadvantages.
At a current price of $12.50, NATIONAL RESEARCH CORP is trading near fair value based on current fundamentals. Our value factor score of 69/100 reflects a composite assessment across multiple valuation metrics including price-to-earnings, price-to-book, EV/EBITDA, and price-to-sales ratios relative to both sector peers and the broader market. Valuation metrics are mixed, with no strong signal of mispricing in either direction.
The stock currently trades at a P/E of 20.0x (roughly in line with the sector median of 23.7x), EV/EBITDA of 9.4x (near the sector median), P/B of 21.6x, P/S of 2.2x. The below-sector P/E suggests possible undervaluation or the market pricing in near-term headwinds.
Gross margins of 61% signal strong pricing power and brand/IP advantages — businesses with margins above 40% have historically demonstrated more resilient earnings through economic cycles.
Returns on equity of 108.2% exceed the cost of equity for most companies, indicating genuine shareholder value creation and a reinvestment engine that compounds wealth over time.
A value factor score of 69/100 suggests the market is underpricing these fundamentals, creating a potential margin of safety for new investors.
Positive momentum (65th percentile) indicates institutional accumulation and favorable technical dynamics that tend to persist in the intermediate term.
A 3.76% dividend yield provides income while you wait, and dividends historically account for a significant portion of total equity returns.
We assign a High uncertainty rating to NATIONAL RESEARCH CORP. Key risk factors include significant leverage (848% debt-to-equity). The wide range of potential outcomes widens our fair value estimate and increases the possibility of permanent capital impairment. Investors considering this name should size positions accordingly and demand a meaningful margin of safety before initiating.
Specific risk factors that inform our assessment include: significant leverage (848% debt-to-equity). Each of these factors independently widens the distribution of potential outcomes, and in combination they create a risk profile that demands careful position sizing. The stability factor at the 52th percentile and quality factor at the 74th percentile provide a quantitative summary of the overall risk landscape.
Key risk mitigants include: healthy gross margins of 61% provide a buffer against cost pressures; a 3.76% dividend yield anchors total return. These factors partially offset the identified risks and provide downside protection in adverse scenarios. On balance, the risk-reward profile warrants caution and disciplined position management.
We rate NATIONAL RESEARCH CORP's capital allocation as Standard. Management has shown adequate — though not exceptional — stewardship of shareholder capital. Returns on equity stand at 108.2%, and the balance sheet is managed within acceptable parameters (D/E: 848%). Exemplary allocators typically sustain ROE above 20% and D/E below 50%; NATIONAL RESEARCH CORP falls short on at least one dimension.
There is room for improvement in optimizing the capital structure or enhancing shareholder returns. The 3.76% dividend yield provides some income return, but the overall capital allocation framework would benefit from either higher reinvestment returns, improved balance sheet efficiency, or increased shareholder distributions. We will monitor for signs of strategic improvement that could warrant an upgrade.
In summary, NATIONAL RESEARCH CORP receives a Hold rating with a composite score of 57.1/100 (rank #1019 of 7,333). Our quantitative framework assigns a No Moat (37/100, trend: stable), High uncertainty, and Standard capital allocation. The average factor score across quality, value, momentum, stability, and investment is 59/100.
Our analysis supports a neutral stance on NATIONAL RESEARCH CORP. While the quantitative profile is not weak enough to warrant selling, it lacks the multi-factor strength required for a buy recommendation. Existing holders should maintain positions and monitor for catalysts — either fundamental improvement or valuation compression — that would shift the risk-reward balance.
Analysis derived from Blank Capital Research quantitative terminal. For informational purposes only. No trade solicitation. Past performance not indicative of future results. Consult a qualified advisor.
We do not assign NATIONAL RESEARCH CORP a meaningful economic moat, scoring 37/100 on our composite assessment. The ROIC-WACC spread of -1.5% is the primary signal of economic value creation. Current fundamentals do not demonstrate the kind of durable competitive advantages — such as superior returns on invested capital, margin superiority, or reinvestment efficiency — that would protect the company from competitive erosion over the long term. The highest-scoring pillar, margin superiority, reached only 14.3/20.
The strongest moat sources are margin superiority (14.3/20) and financial resilience (8.8/20). GM 61% vs sector 60%, OM 19% vs sector 4%. Interest coverage 5.3x, Net debt/EBITDA 7.8x. These pillars form the core of NATIONAL RESEARCH CORP's competitive identity and are the primary drivers of excess returns in our framework.
Areas of relative weakness include reinvestment efficiency (0/20) and economic value creation (6.7/20). Capital turnover 0.44x. Improvement in these areas could meaningfully widen the moat over time, while deterioration would be an early warning of competitive erosion.
Our moat trend assessment is Stable. Multi-year ROIC and operating margin trajectories show neither meaningful improvement nor deterioration, suggesting the competitive position is steady. We expect NATIONAL RESEARCH CORP's moat profile to remain largely unchanged absent a material shift in return on capital or industry dynamics.
Key profit drivers include gross margins of 61% providing a solid profitability foundation, operating margins of 19% reflecting effective cost management, declining revenues (-1%) that pressure the earnings outlook. The margin cascade from 61% gross to 19% operating to 11.2% net reveals the company's cost structure and reinvestment intensity. Our analysis indicates that the profit engine is high-quality and likely sustainable, with the quality factor at the 74th percentile.
The margin profile shows gross margins of 61%, operating margins of 19%, net margins of 11.2%. Return metrics include ROE of 108.2% and ROA of 11.4%. Relative to the Services sector, gross margins are 1.5 percentage points above the sector median of 60%, and ROE of 108.2% compares to a sector median of 5.3%.
The balance sheet reflects high leverage with D/E of 848%, which may limit financial flexibility, a dividend yield of 3.76%, revenue growth of -1%. The sector median D/E is 0%, putting NATIONAL RESEARCH CORP at higher leverage than the typical peer. Elevated leverage in combination with the current margin profile warrants close monitoring for any deterioration in debt-servicing capacity.
Elevated leverage (848% D/E) amplifies downside risk and limits management's financial flexibility in adverse scenarios.
Revenue decline of -1% signals business deterioration — declining revenues make it difficult to grow into the current valuation and often precede further negative revisions.
Above 50MA
37.18%
Net New Highs
+51081
NEW YORK, February 18, 2026--Hadron Energy, Inc. ("Hadron" or the "Company") today announced that the U.S. Nuclear Regulatory Commission ("NRC") will hold a public meeting on February 19, 2026, to discuss the NRC staff’s review of Hadron’s Quality Assurance Program Description ("QAPD") Topical Report in support of the Company’s Halo Micro-Modular Reactor ("MMR") licensing pathway.
OAK RIDGE, Tenn., February 13, 2026--TRISO-X, LLC ("TRISO-X" or the "Company"), a subsidiary of X-energy Reactor Company, LLC ("X-energy") today received a Special Nuclear Material License under 10 CFR Part 70 ("Part 70") from the U.S. Nuclear Regulatory Commission ("NRC"), enabling TRISO-X to commercially manufacture fuel using high-assay low-enriched uranium ("HALEU") at its first two commercial facilities ("TX-1" and "TX-2") under an initial 40-year license. NRC license approval formally esta
The global revival of nuclear energy has put NuScale Power in the spotlight.
The Trump administration is making moves to loosen the environmental rules for nuclear energy. Earlier this month, the Energy Department published an exclusion to environmental reviews for the reactors under its jurisdiction. And it could be loosening other rules, including radiation limits. But the biggest changes could be still to come from the relatively low-profile…
NRC Health's Q4 EPS and revenues decline year amid prior client attrition, though recurring contract value grew 8%, pointing to recovery prospects in 2026.